3-Benzyl-7-oxa-3-azabicyclo[4.1.0]heptane

Catalog No. :
ACQFAZ539
CAS No. :
725715-12-8
Molecular Formula :
C12H15NO
Molecular Weight :
189.26

IUPAC Name:3-benzyl-7-oxa-3-azabicyclo[4.1.0]heptane

3-Benzyl-7-oxa-3-azabicyclo[4.1.0]heptane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$58.00Login to see priceIn stockIn stock
25g97%$173.00Login to see priceIn stockIn stock
100g97%$552.00Login to see priceIn stockInquiry
500g97%$2291.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Benzyl-7-oxa-3-azabicyclo[4.1.0]heptane
IUPAC Name3-benzyl-7-oxa-3-azabicyclo[4.1.0]heptane
MDL No.MFCD18785747
Molecular FormulaC12H15NO
Molecular Weight189.26
SMILESC12CN(CC3=CC=CC=C3)CCC1O2
InChI KeyJFKIYXNTBUQZJM-UHFFFAOYSA-N
SynonymCS-0183212 | A23050 | DTXSID301234861 | 3-benzyl-7-oxa-3-azabicyclo[4.1.0]heptane | 3-benzyl-7-oxa-3-aza-bicyclo[4.1.0]heptane | 3-benzyl-7-oxa-3-aza-bicyclo[4.1.0]heptane;3-Benzyl-7-oxa-3-azabicyclo[4.1.0]heptane | MFCD18785747 | BS-42892 | FT-0690179 |
CAS No.725715-12-8
PubChem CID6421496

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACQFAZ539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHGAM135 route compound structure diagram
    ACHGAM13540240-12-8 In Stock
  2. Then
  3. ACQFAZ539 route product structure diagram
    ACQFAZ539725715-12-8 In Stock
Inquiry

2. ACQFAZ539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHGAM135 route compound structure diagram
    ACHGAM13540240-12-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQFAZ539 route product structure diagram
    ACQFAZ539725715-12-8 In Stock
Inquiry

Comments (0)